Hot Features
プレミアム
Sensient Technologies Corp (SXT)
NYSE
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Thierry Hoangインサイダー | -400.00 | 46.08k | 売り | 115.19 | 13.91k | -2.80% |
| 2026-05-04 | Thierry Hoangインサイダー | -439.00 | 50.11k | 売り | 114.15 | 14.31k | -2.98% |
| 2026-04-30 | Mr. Steve MorrisPresident of Color Group | -200.00 | 22.92k | 売り | 114.58 | 7.94k | -2.46% |
| 2026-04-30 | Freemont Capital Pte. Ltd.法人 | -2.13M | 233.37M | 売り | 109.69 | 4.18M | -33.74% |
| 2026-04-23 | Dr. Donald W. LandryIndependent Director & Member of Scientific Advisory Committee | -674.00 | 66.88k | Sale to Issuer | 99.23 | 10.45k | -6.06% |
| 2026-04-23 | Mr. Brett W. BruggemanIndependent Director & Member of Scientific Advisory Committee | -283.00 | 28.08k | Sale to Issuer | 99.23 | 3.57k | -7.35% |
| 2026-04-23 | Dr. Mario G. FerruzziIndependent Director & Chairman of Scientific Advisory Committee | -674.00 | 66.88k | Sale to Issuer | 99.23 | 8.75k | -7.15% |
| 2026-04-23 | Ms. Carol R. JacksonIndependent Director & Member of Scientific Advisory Committee | -674.00 | 66.88k | Sale to Issuer | 99.23 | 6.54k | -9.34% |
| 2026-04-23 | Mr. Scott C. MorrisonIndependent Director & Member of Scientific Advisory Committee | -674.00 | 66.88k | Sale to Issuer | 99.23 | 11.55k | -5.52% |
| 2026-04-23 | Ms. Essie Mae WhitelawDirector & Member of Scientific Advisory Committee | -674.00 | 66.88k | Sale to Issuer | 99.23 | 17.58k | -3.69% |
| 2026-03-02 | Mr. Steve MorrisPresident of Color Group | -373.00 | 37.52k | Sale to Issuer | 100.58 | 8.09k | -4.41% |
| 2026-03-02 | Mr. Adam VanderleestVP, Controller & CAO | -133.00 | 13.38k | Sale to Issuer | 100.58 | 2.41k | -5.24% |
| 2026-02-12 | Mr. Michael C. GeraghtyMember of Scientific Advisory Committee | 2.46k | 0.00 | Derivative Exercise and Retained Stock | - | 46.35k | 5.61% |
| 2026-02-12 | Mr. Michael C. GeraghtyMember of Scientific Advisory Committee | -2.46k | 241.10k | Derivative Exercise and Sale | 97.93 | 46.35k | - |
| 2026-02-12 | Thierry Hoangインサイダー | 1.29k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 9.61% |
| 2026-02-12 | Ms. Amy Schmidt JonesVP of HR & Senior Counsel | 1.69k | 0.00 | Derivative Exercise and Retained Stock | - | 25.98k | 6.98% |
| 2026-02-12 | Ms. Amy Schmidt JonesVP of HR & Senior Counsel | -1.69k | 165.89k | Derivative Exercise and Sale | 97.93 | 25.98k | - |
| 2026-02-12 | Mr. John J. ManningSenior VP, General Counsel & Secretary | 2.01k | 0.00 | Derivative Exercise and Retained Stock | - | 36.32k | 5.85% |
| 2026-02-12 | Mr. John J. ManningSenior VP, General Counsel & Secretary | -2.01k | 196.64k | Derivative Exercise and Sale | 97.93 | 36.32k | - |
| 2026-02-12 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | 15.01k | 0.00 | Derivative Exercise and Retained Stock | - | 280.15k | 5.66% |
| 2026-02-12 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | -15.01k | 1.47M | Derivative Exercise and Sale | 97.93 | 280.15k | - |
| 2026-02-12 | Mr. Tobin TornehlVP & CFO | 751.00 | 0.00 | Derivative Exercise and Retained Stock | - | 16.46k | 4.78% |
| 2026-02-12 | Mr. Tobin TornehlVP & CFO | -751.00 | 73.55k | Derivative Exercise and Sale | 97.93 | 16.46k | - |
| 2025-12-08 | Mr. Tobin TornehlVP & CFO | -586.00 | 52.75k | Sale to Issuer | 90.02 | 12.81k | -4.38% |
| 2025-12-08 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | -11.72k | 1.06M | Sale to Issuer | 90.02 | 245.44k | -4.56% |
| 2025-12-08 | Mr. John J. ManningSenior VP, General Counsel & Secretary | -1.57k | 141.06k | Sale to Issuer | 90.02 | 31.51k | -4.74% |
| 2025-12-08 | Ms. Amy Schmidt JonesVP of HR & Senior Counsel | -1.32k | 119.01k | Sale to Issuer | 90.02 | 22.00k | -5.67% |
| 2025-12-08 | Mr. Michael C. GeraghtyMember of Scientific Advisory Committee | -1.92k | 172.93k | Sale to Issuer | 90.02 | 40.46k | -4.53% |
| 2025-11-20 | Ms. Essie Mae WhitelawDirector & Member of Scientific Advisory Committee | -4.52k | 428.38k | 売り | 93.22 - 95.02 | 17.13k | -20.87% |
| 2025-11-04 | Mr. David J. PlautzVP of Investor Relations & Treasurer | 2.15k | 199.91k | 買い | 92.98 | 3.22k | 200.37% |
| 2025-11-03 | Dr. Joseph CarleoneIndependent Lead Director & Member of Scientific Advisory Committee | 1,000.00 | 91.26k | 買い | 91.26 | 22.41k | 4.67% |
| 2025-08-11 | Mr. Paul ManningChairman, CEO, President & Member of Scientific Advisory Committee | 20.00 | 2.34k | 買い | 116.94 | 257.15k | 0.01% |
| 2025-08-06 | Mr. Sharad P. JainIndependent Director & Member of Scientific Advisory Committee | -1.23 | 140.51 | 売り | 114.14 | 5.81k | -0.02% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
